The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.Oxford and AstraZeneca resume coronavirus vaccine trial
By PAN PYLAS LONDON©2024 GPlusMedia Inc.
5 Comments
Login to comment
Vanessa Carlisle
Really? My suggestion is to start gloating when the war is over not during these minor battles.
Did you notice that not one word was said about effectiveness in the article? Even on the safety said there was no word on tests on the age and health related groups who will need this the most.
Both omissions make me think its maybe 20 to 40 percent effective and they are testing it on relatively young healthy people.
Naturally I will be labeled as "anti-vaxx" for not displaying unbridled cheerleader-ish confidence in these pointedly unnamed test vaccines, even though I go totally case by case regarding vaccines and as such totally approve of some. But that's everything now isn't? You are either with us or the enemy right?
virusrex
You know what is hugely more likely to produce unexpected side effects and diseases? the natural infection, even if asymptomatic. It produces a dozen extra viral proteins, some made specifically to mess up with the immune system and in a million time larger scales than a vaccine.
Epidemiologically speaking it is terribly simple to find out the reason of something that elevates even slightly the incidence of a disease, as long as the reason is registered. Until now "chemicals" in the vaccines has not been related to cancer, in difference to some viral infections that actually do.
The news is about the resuming of the tests because of observed problems with one volunteer (between literally thousands), effectiveness has already been proved in the preclinical trials and previous phases of the clinical trials, else there would be no reason to continue to phase III, if you go to clinicaltrials.gov and search for NCT04516746 you can see a lot more of details, including that population in special risk for COVID-19 are part of the target group. Since the trial has just began and is blinded it is not logical to expect results from this phase to be available, specially since it is a two dose schedule.
What does that even mean? 20-40% less viral loads? reduction of risk for complications? reduction of fatalities? presentation of symptoms? again, what makes you expect results from a study that has just begun?
Not really, disregarding scientific information that you ignore, even if it is actually available, or putting an unrealistic standard of proof for the vaccine that does not apply to anything else (like having results before running the tests) may get you called that, but a real antivaxxer is just the person that in unable to accept that a vaccine may be actually safe and effective after the tests are finished.
It is not the same to say we don't have yet the evidence of the phase III (so we cannot know yet how effective and safe the vaccine actually is) and saying that results do not matter, the vaccine has to be poison no matter what.
Yrral
These vaccine are not guaranteed to stop a person, from contracting the virus, just lessened the severity of the virus effect